Nitric oxide-releasing nanoparticles improve doxorubicin anticancer activity.

Int J Nanomedicine · 2018 · PMC6251458 · PMID 30538458

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Local administration of SMA-tDodSNO (1 mg/kg) increased the tumor concentration of SMA-Dox 24 hours after the injections (1.65-fold of SMA-Dox alone); however, the difference did not reach statistical significance ( Figure 9 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.